{"id":"W3111386845","doi":"10.1111/ejh.13564","title":"One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Adverse effect; Internal medicine; Anemia; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003630004,0.001502117,0.002808383,0.0003183505,0.000535188,0.001272858,0.0008180022,0.001664593,0.004383077],"category_scores_gemma":[0.003030465,0.0006507477,0.004222431,0.0003028437,0.0006558161,0.001018649,0.000477827,0.003701572,0.0006179232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000737862,"about_ca_system_score_gemma":0.000777363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001055786,"about_ca_topic_score_gemma":0.002182734,"domain_scores_codex":[0.9986494,0.0007359432,0.0001129997,0.00022858,0.000100724,0.0001723955],"domain_scores_gemma":[0.997974,0.0006006127,0.0006044839,0.0001986753,0.0001397803,0.0004825221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.976863,0.00343147,0.001828083,0.0004872172,0.003785441,0.00005925481,0.00005744641,0.0003964059,0.002068943,0.00006015609,0.0009416059,0.01002097],"study_design_scores_gemma":[0.8913254,0.0871769,0.01527457,0.00008133902,0.003907501,0.0001076457,0.00004057446,0.0006253587,0.0005950904,0.0001546082,0.0006771691,0.00003383608],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891583,0.005947666,0.0004764192,0.0004382818,0.0002822007,0.001217956,0.001230849,0.00006047577,0.001187837],"genre_scores_gemma":[0.9923199,0.001726391,0.0005962822,0.0007854396,0.0002176427,0.001538318,0.001616085,0.00001695675,0.001183035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004383077,"threshold_uncertainty_score":0.01919746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02286949683580114,"score_gpt":0.2583178488033262,"score_spread":0.2354483519675251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}